Here, we report the follow-up functional studies of a novel frameshift mutation, p.Gly664Glufs*70, identified as de novo in an individual presenting with autism spectrum disorder (ASD), which replaced the last 47 C-terminal GAR residues of nucleolin protein with 69 non-GAR residues (Figure 1D). This evidence concerns the gene NUCLEOLIN and autism spectrum disorder.